Can-Fite Selected to Deliver Late-Breaking Oral Presentation on Namodenoson's Treatment of NASH at American Association for the Study of Liver Diseases Conference
Stock Information for Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Loading
Please wait while we load your information from QuoteMedia.